Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT2 in Focal Articular Cartilage Lesions of the Knee
NCT04236739Phase 3Completed
- Start
- Jul 2019
- Primary completion
- Sep 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous chondrons + allogeneic mesenchymal stromal cells in chondropathy. Started Jul 2019; status: completed.
02
Drugs
autologous chondrons + allogeneic mesenchymal stromal cells
03
Conditions
chondropathy
Beyond the preview
Go deeper on NCT04236739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236739.